Jeppesen Mette Moustgaard, Mogensen Ole, Hansen Dorte Gilså, Iachina Maria, Korsholm Malene, Jensen Pernille Tine
a Department of Gynaecology and Obstetrics, Faculty of Health Sciences , Odense University Hospital, Clinical Institute, University of Southern Denmark , Odense , Denmark.
b Department of Obstetrics and Gynaecology , Karolinska University Hospital, Sweden and Clinical Institute, University of Southern Denmark , Odense , Denmark.
Acta Oncol. 2017 Feb;56(2):262-269. doi: 10.1080/0284186X.2016.1267396. Epub 2017 Jan 12.
Considerable controversy remains as to the optimal organization of endometrial cancer follow-up.
To evaluate the relationship between the way recurrence was detected and survival after treatment for endometrial cancer. Further, to identify characteristics associated with a pre-scheduled examination in women with symptomatic recurrence.
All women with early stage endometrial cancer during 2005-2009 were included in a population-based historical cohort derived from the Danish Gynecological Cancer Database. Women diagnosed with recurrence within three years after primary surgery and the mode of recurrence detection were identified from hospital charts: asymptomatic recurrence detected at regular follow-up, symptomatic recurrence detected at regular follow-up or symptomatic recurrence detected in between follow-up. Survival of women with symptomatic and asymptomatic disease was compared. Furthermore, characteristics associated with self-referral as compared to presenting symptoms at regular follow-ups were identified using univariate analyses.
In total, 183 cases of recurrence (7%) were identified in the cohort of 2612 women. Of these, 65.5% were symptomatic with vaginal bleeding as the most prevalent symptom. Asymptomatic women had a significantly better three-year survival rate compared to symptomatic women (80.3% vs. 54.3%, p < 0.01). A total of 2.3% of the entire population had an asymptomatic recurrence. Women diagnosed at a pre-scheduled visit due to symptoms had a higher educational level (p = 0.03) and more often high-risk disease (p = 0.02) than symptomatic women diagnosed at regular follow-up.
Early stage endometrial cancer carries a low risk of recurrence. Survival appears to be superior in asymptomatic patients, but length-time bias, i.e. the effect of aggressive tumor biology in symptomatic recurrences, may bias results in non-randomized controlled trials. Well educated patients with symptoms of recurrence more often sought medical attendance compared to less educated counterparts. This should be considered if patient-initiated follow-up is the standard care.
关于子宫内膜癌随访的最佳组织方式仍存在相当大的争议。
评估子宫内膜癌治疗后复发检测方式与生存率之间的关系。此外,确定有症状复发女性中与预定检查相关的特征。
2005年至2009年期间所有早期子宫内膜癌女性被纳入基于丹麦妇科癌症数据库的人群历史队列。从医院病历中识别出在初次手术后三年内诊断为复发的女性以及复发检测方式:在定期随访中检测到的无症状复发、在定期随访中检测到的有症状复发或在随访期间检测到的有症状复发。比较有症状和无症状疾病女性的生存率。此外,使用单变量分析确定与自我转诊相比在定期随访中出现症状相关的特征。
在2612名女性队列中总共识别出183例复发(7%)。其中,65.5%有症状,最常见症状为阴道出血。无症状女性的三年生存率明显高于有症状女性(80.3%对54.3%,p<0.01)。整个人口中共有2.3%有无症状复发。因症状在预定就诊时被诊断的女性比在定期随访中被诊断的有症状女性教育水平更高(p=0.03),且高危疾病更常见(p=0.02)。
早期子宫内膜癌复发风险较低。无症状患者的生存率似乎更高,但长度偏倚,即有症状复发中侵袭性肿瘤生物学的影响,可能会使非随机对照试验的结果产生偏差。与受教育程度较低的患者相比,有复发症状的受过良好教育的患者更常寻求医疗护理。如果患者发起的随访是标准护理,则应考虑这一点。